CEO John Barry Reports a $997,219 $PSEC Buy

Every day, we sift through the filings to spot where the real conviction lies – cutting through the noise to highlight the most meaningful insider moves.

Here's what stood out today:

📌 Prospect Capital $PSEC – CEO John F. Barry filed a Form 4 for $997,219.
 
Big, clean buy in a BDC. Notable executive conviction in the yield machine as shares trade at their lowest on an absolute basis. 

📌 Arvinas $ARVN – Director Briggs Morrison filed a Form 4 for $227,010.

Specialist biotech operator putting fresh skin in the game as shares trade in a tight range near all-time lows.

Here’s The Hot Corner, with data from September 24, 2025:

Click the table to enlarge it.

📌 Oruka Therapeutics $ORKA – Viking Global Investors filed an initial 13G at 5.50%.

Tier-one hedge fund planting a meaningful passive flag in a new biotech. Interesting timing, as the stock fell over 90% last year. Maybe they’re betting the gap gets filled soon. 

📌 Doximity $DOCS — Rep. Jonathan Jackson disclosed a purchase of $15,001 to $50,000 on September 24, 2025.